Taflan Eye Drop
Indication
Elevated Intraocular Pressure
Administration
Instill into conjunctival sac of affected eye(s) Do not exceed once daily dosing regimen; more frequent administration of prostaglandin analogs may lessen the IOP lowering effect Reduction of intraocular pressure starts approximately 2 - 4 hours after first administration with maximum effect reached after 12 hr If other topical ophthalmics are prescribed, each should be administered 5 minutes apart
Adult Dose
Elevated Intraocular Pressure Indicated for reducing elevated IOP in patients with open-angle glaucoma or ocular hypertension Instill 1 drop in affected eye(s) once daily in the evening
Mode of Action
Prostaglandin analog; exact mechanism by which it reduces IOP is unknown, but it is thought to increase uveoscleral outflow
Precaution
Causes changes to pigmented tissues; most frequently reported changes have been of the iris, eyelid, and eyelashes; pigmentation changes of the iris is likely permanent Increases length, color, thickness, and number of eyelashes Caution with active intraocular inflammation (may exacerbate condition) Macular edema reported; caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or with known risk factors for macular edema. Lactation: Unknown whether distributed in breast milk.
Side Effect
>10% Conjunctival hyperemia (4-20%) 1-10% Ocular stinging (7%),Ocular pruritus/allergic conjunctivitis (5%),Cataract (3%),Growth of eyelashes (2%),Blurred vision (2%)